Cargando…
Treatment with OPG and cellular gene therapy with IL-4 decrease bone resorption-associated inflammation in collagen-induced arthritis
Autores principales: | Saidenberg-Kermanac'h, N, Bessis, N, de Vernejoul, M-C, Boissier, MC, Cohen-Solal, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833644/ http://dx.doi.org/10.1186/ar707 |
Ejemplares similares
-
Protection of inflammation-related bone loss by OPG and TNF-α antibodies through distinct mechanisms in collagen-induced arthritis
por: Saidenberg-Kermanach, N, et al.
Publicado: (2004) -
Bone sparing effect of osteoprotegerin and anti-inflammatory cytokines in collagen-induced arthritis
por: de Vernejoul, M, et al.
Publicado: (2003) -
AAV mediated delivery of IL-4 prevents collagen-induced arthritis
por: Bessis, N, et al.
Publicado: (2001) -
Nonviral gene therapy by electrotransfer of hTNF-α soluble receptor variants: application to the treatment of collagen arthritis
por: Bloquel, C, et al.
Publicado: (2004) -
Bone fragility in sarcoidosis and relationships with calcium metabolism disorders: a cross sectional study on 142 patients
por: Saidenberg-Kermanac’h, Nathalie, et al.
Publicado: (2014)